Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| NCI-2020-00697 | Registry Identifier | CTRP (Clinical Trial Reporting Program) | |
| I 82819 | Other Identifier | Roswell Park Cancer Institute |
Not provided
Not provided
Not provided
low accrual
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This trial studies the main and interactive effects of episodic future thinking and future thinking priming tasks on helping participants to quit smoking. Episodic future thinking and future thinking priming tasks may decrease delay discounting rates and reduce relapse to smoking and help participants quit smoking.
PRIMARY OBJECTIVE:
I. To quantify the main and interactive effects of the episodic future thinking (EFT) and future thinking priming (FTP) tasks on delay discounting rate, latency to relapse, and multiple abstinence and self-regulation measures among smokers (n=76) who call a busy Quitline to quit smoking.
OUTLINE: Participants are randomized to 1 of 4 arms.
ARM I: Participants are provided with Forever Free relapse prevention booklets and receive a 2-week supply of nicotine patches, gum, or lozenges. Participants also receive 1 proactive coaching call within 24 hours of quit date. Beginning on the quit date, participants complete an active episodic future thinking or active future thinking priming task once per week for 12 weeks, alternating every week between tasks.
ARM II: Participants are provided with Forever Free relapse prevention booklets and receive a 2-week supply of nicotine patches, gum, or lozenges. Participants also receive 1 proactive coaching call within 24 hours of quit date. Beginning on the quit date, participants complete an active episodic future thinking or control future thinking priming task once per week for 12 weeks, alternating every week between tasks.
ARM III: Participants are provided with Forever Free relapse prevention booklets and receive a 2-week supply of nicotine patches, gum, or lozenges. Participants also receive 1 proactive coaching call within 24 hours of quit date. Beginning on the quit date, participants complete a control episodic future thinking or active future thinking priming task once per week for 12 weeks, alternating every week between tasks.
ARM IV: Participants are provided with Forever Free relapse prevention booklets and receive a 2-week supply of nicotine patches, gum, or lozenges. Participants also receive 1 proactive coaching call within 24 hours of quit date. Beginning on the quit date, participants complete a control episodic future thinking or control future thinking priming tasks once per week for 12 weeks, alternating every week between tasks.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Arm I (active EFT, active FTP) | Experimental | Participants are provided with Forever Free relapse prevention booklets and receive a 2-week supply of nicotine patches, gum, or lozenges. Participants also receive 1 proactive coaching call within 24 hours of quit date. Beginning on the quit date, participants complete an active episodic future thinking or active future thinking priming task once per week for 12 weeks, alternating every week between tasks. |
|
| Arm II (active EFT, control FTP) | Experimental | Participants are provided with Forever Free relapse prevention booklets and receive a 2-week supply of nicotine patches, gum, or lozenges. Participants also receive 1 proactive coaching call within 24 hours of quit date. Beginning on the quit date, participants complete an active episodic future thinking or control future thinking priming task once per week for 12 weeks, alternating every week between tasks. |
|
| Arm III (control EFT, active FTP) | Experimental | Participants are provided with Forever Free relapse prevention booklets and receive a 2-week supply of nicotine patches, gum, or lozenges. Participants also receive 1 proactive coaching call within 24 hours of quit date. Beginning on the quit date, participants complete a control episodic future thinking or active future thinking priming task once per week for 12 weeks, alternating every week between tasks. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Behavioral Intervention | Behavioral | Complete active episodic thinking task |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in Delay discounting rate | Assessed with the 5-Trial Adjusting Delay Discounting. | Baseline, and 4 and 12 weeks after quit date |
| Latency to relapse | Will be assessed with the Timeline Follow-Back procedure administered by telephone. Analyzed using generalized mixed models. | Baseline, assessed up to 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Latency to first relapse | Defined as the number of days until first relapse (any smoking for seven consecutive days). Will be assessed with the Timeline Follow-Back procedure administered by telephone. Analyzed using generalized mixed models. | up to 12 weeks |
| Number of days abstinent |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Christine Sheffer | Roswell Park Cancer Institute | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Arm IV (control EFT, control TFP) | Active Comparator | Participants are provided with Forever Free relapse prevention booklets and receive a 2-week supply of nicotine patches, gum, or lozenges. Participants also receive 1 proactive coaching call within 24 hours of quit date. Beginning on the quit date, participants complete a control episodic future thinking or control future thinking priming tasks once per week for 12 weeks, alternating every week between tasks. |
|
| Behavioral Intervention | Behavioral | Complete active future thinking priming task |
|
|
| Behavioral Intervention | Behavioral | Complete control episodic future thinking task |
|
|
| Behavioral Intervention | Behavioral | Complete control future thinking priming task |
|
|
| Informational Intervention | Other | Provided with Forever Free relapse prevention booklet |
|
| Nicotine Replacement | Drug | Receive nicotine patches, gum, or lozenges |
|
|
| Telephone-Based Intervention | Other | Receive coaching call |
|
Will be evaluated by cox proportional-hazards survival model analyses. |
| Up to 12 weeks |
| 7-day point prevalence abstinence rates | Will be evaluated by cox proportional-hazards survival model analyses. | At 4 and 12 weeks after quit date |
| Attentional, motor, and non-planning impulsiveness | Assessed with the Barratt Impulsiveness Scale. | Up to 12 weeks |
| Behavioral inhibition and behavioral activation | Assessed with the Behavioral Avoidance/Inhibition scales. | Up to 12 weeks |
| Self-control | Assessed with the Brief Self-Control Survey. | Up to 12 weeks |
| Ability to regulate behavior to achieve goals | Assessed with the Short Self-Regulation Questionnaire. | Up to 12 weeks |
| ID | Term |
|---|---|
| D001521 | Behavior Therapy |
| D000095488 | Nicotine Replacement Therapy |
| ID | Term |
|---|---|
| D011613 | Psychotherapy |
| D004191 | Behavioral Disciplines and Activities |
| D004358 | Drug Therapy |
| D013812 | Therapeutics |
Not provided
Not provided